| Name | Mediclinic International |
|---|---|
| Epic | MDC |
| Isin | GB00B8HX8Z88 |
| Index | UK250 UK350 |
| Industry | Medical Equipment and Services |
| Latest share price | 501.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £3,693.59 | Debt ratio | n/a |
| Shares in issue | 737.24 | Debt-to-equity ratio | n/a |
| P/E ratio | 15.8 | Assets / equity ratio | n/a |
| Total dividends per share | 3.00p | Price to book value | n/a |
| Dividend yield | 0.8 | ROCE | 5.39 |
| Dividend cover | 7.53 | EPS growth | 65 |
| Earning per share | 20.5 | 52-week high / low | 378.40p / 501.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2022-08-04 | 2022-08-26 | 3.00p |
| Interim | 2019-12-05 | 2019-12-17 | 3.20p |
| Final | 2019-06-13 | 2019-07-29 | 4.70p |
| Interim | 2018-12-06 | 2018-12-18 | 3.20p |
| Final | 2018-06-14 | 2018-07-30 | 4.70p |
| Interim | 2017-12-07 | 2017-12-18 | 3.20p |
| Company name | Mediclinic International |
|---|---|
| Address | 6th Floor, 65 Gresham Street, London, United Kingdom, EC2V 7NQ |
| Telephone | +44 333 300 1930 |
| Website | http://www.mediclinic.com |
| Director | Position |
|---|---|
| Mr Jannie Durand | Non-Executive Director |
| Mr Danie Meintjes | Non-Executive Director |
| Ms Dame Inga Beale | Non-Executive Chairman |
| Dr Felicity A. H Harvey | Senior Independent Director |
| Dr Ronnie van der Merwe | Group Chief Executive |
| Mr Tom Singer | Independent Non-Executive Director |
| Ms Zarina Bassa | Independent Non-Executive Director |
| Mr Steve Weiner | Independent Non-Executive Director |
| Dr Anja Oswald | Independent Non-Executive Director |
| Ms Natalia Barsegiyan | Independent Non-Executive Director |
| Dr Muhadditha Yahya Al Hashimi | Independent Non-Executive Director |
| Mr Petrus Jurgens Myburgh | Group CFO |
| Assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Reporting date | 31/03/22 | 31/03/21 | 31/03/20 |
| Intangible asssets and goodwill | 1126 | 1061 | 1171 |
| Investments and other non-current assets | 189 | 183 | 190 |
| Total non-current assets | 5733 | 5440 | 5741 |
| Inventory / work in progress | 97 | 109 | 104 |
| Trade and other receivables | 834 | 826 | 766 |
| Cash and equivalents | 534 | 294 | 329 |
| Other current assets and asset held for resale | 9 | 3 | 14 |
| Total of all assets | 7207 | 6672 | 6954 |
| Liabilities £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Short term liabilities | 823 | 684 | 769 |
| Long term liabilities | 3138 | 3021 | 3182 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 3961 | 3705 | 3951 |
| Net assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net assets | 3246 | 2967 | 3003 |
| Equity £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Share capital | 74 | 74 | 74 |
| Minority interests | 139 | 118 | 113 |
| Retained earnings | 4597 | 4523 | 4327 |
| Share premium account | 690 | 690 | 690 |
| Total equity | 3246 | 2967 | 3003 |
| Income £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 280 | 209 | -184 |
| Pre-tax profit | 211 | 104 | -275 |